Skip to main content
. 2018 May 24;13(5):e0197323. doi: 10.1371/journal.pone.0197323

Table 3. Percentual component concentration of the formulations proposed for the tablet.

Component* Formulation 1 (%) Formulation 2 (%) Formulation 3 (%)
MC 102 35.50 33.00 41.00
PVP K-30 2.50 5.00 1.00
TAL 10.00 10.00 10.00
CSD 1.00 1.00 1.00
CRO 5.00 5.00 1.00
AMCA 46.00 46.00 46.00

*MC 102: microcrystalline cellulose PH 102; PVP K-30: polyvinylpyrrolidone K-30; TAL: talc; CSD: colloidal silicone dioxide; CRO: sodium croscarmellose; AMCA: X. americana dry extract.